Laure Lacoin
Impact in
- Toxicology top 10%
-
- Hepatitis C virus research
Papers in
-
- Lung Cancer Treatments and Mutations 14
- Lung Cancer Diagnosis and Treatment 10
- Oncology 8
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 4
- Co-authors
- M. Daumont (24 shared papers)John R. Penrod (13 shared papers)Cinira Lefèvre (3 shared papers)John C. O’Donnell (13 shared papers)M. Snee (8 shared papers)C. Chaib (12 shared papers)Nicholas Moore (4 shared papers)Alan Calleja (6 shared papers)
- Journals
- Annals of Oncology (7 papers)BMJ Open (4 papers)Journal of Thoracic Oncology (3 papers)Lung Cancer (3 papers)BMC Pulmonary Medicine (2 papers)
- Partner nations
- United KingdomBelgiumUnited States
In The Last Decade
Laure Lacoin
34 papers receiving 294 citations
Peers
Comparison fields: 5 of 50
- Toxicology 19
- Hepatology 23
- Pulmonary and Respiratory Medicine 89
- Oncology 57
- Cardiology and Cardiovascular Medicine 27
Countries citing papers authored by Laure Lacoin
This map shows the geographic impact of Laure Lacoin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laure Lacoin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laure Lacoin more than expected).
Fields of papers citing papers by Laure Lacoin
This network shows the impact of papers produced by Laure Lacoin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laure Lacoin. The network helps show where Laure Lacoin may publish in the future.
Co-authors
The 25 scholars most cited alongside Laure Lacoin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 30 | |
| 2 | 2019 | 24 | |
| 3 | 2012 | 21 | |
| 4 | 2020 | 21 | |
| 5 | 2016 | 20 | |
| 6 | 2022 | 19 | |
| 7 | 2021 | 19 | |
| 8 | 2013 | 15 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 13 | |
| 12 | 2013 | 13 | |
| 13 | 2021 | 10 | |
| 14 | 2010 | 7 | |
| 15 | 2021 | 6 | |
| 16 | 2022 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2019 | 5 | |
| 19 | 2021 | 5 | |
| 20 | 2023 | 4 |
About Laure Lacoin
Laure Lacoin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Toxicology, Epidemiology and Surgery, having authored 34 papers that have together received 298 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Diagnosis and Treatment (10 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Research Studies (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Multiple and Secondary Primary Cancers (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Toxicology (19 citations), Hepatology (23 citations), Pulmonary and Respiratory Medicine (89 citations), Oncology (57 citations) and Cardiology and Cardiovascular Medicine (27 citations). Laure Lacoin has collaborated with scholars based in United Kingdom, Belgium and United States. Frequent co-authors include M. Daumont, John R. Penrod, Cinira Lefèvre, John C. O’Donnell, M. Snee, C. Chaib, Nicholas Moore, Alan Calleja, Robert Carroll and Simon Ekman. Their work appears in journals such as Annals of Oncology, BMJ Open, Journal of Thoracic Oncology, Lung Cancer and BMC Pulmonary Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.